UnitedHealth, Mayo Clinic in pact to improve patient care
January 18, 2013 by MassDevice staff
UnitedHealth and the Mayo Clinic ink a pact to merge insurance and medical data to improve or standardize care and lower healthcare costs.
UnitedHealth Group, the largest American health insurer, and the Mayo Clinic are joing up to merge insurance records and medical data to help standardize care and lower costs.
The initiative, including a Mayo/Optum Labs venture announced earlier this week, aims to optimize treatments like hip replacements or medication compliance, according to Veronique Roger, head of Mayo's Center for the Science of Health Delivery.
Sign up to get our free newsletters delivered right to your inbox.
"Every doctor, every nurse, every academic medical center wants only to do the right thing for their patients," May CEO John Noseworthy said, according to a Bloomberg report.
UnitedHealth Group CEO Stephen Hemsley said another goal is to create "a neutral place to conduct research" with partners across the healthcare industry and publish the results, the Wall Street Journal reported.
The Optum/Mayo Clinic joint venture, Optum Labs, is looking to improve the quality of long-term patient care.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
Navigation
NEWS
ArtVentive Medical wins CE Mark for peripheral catheter
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
Recalls: FDA makes Endologix catheter introducer recall Class I
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
pSivida gains big on buyout rumor
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
Online insurance marketplaces face challenges
Experts fear the online health insurance marketplace will be burdened with tech problems and...
Mirabilis Medica pulls in $13M Series A round for ultrasound fibroid device
Women's health company Mirabilis Medica lands up to $13 million in Series A round to back its...
